Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act
Section 1003 of the SUPPORT Act amends Title XIX with a provision directing CMS, in consultation with the Substance Abuse and Mental Health Services Administration (SAMHSA), to conduct a 54-month demonstration project to increase the treatment capacity of providers participating in Medicaid to provide substance use disorder (SUD) treatment or recovery services. Planning grants will be awarded to at least 10 states for the first 18 months of the demonstration. Up to 5 states that receive planning grants will be selected to implement 36-month demonstrations. Planning Grants: For the 18-month planning phase of the project, under section 1003(aa)(2)(A) (I-IV)), the HHS Secretary shall award planning grants totaling $50 million to at least 10 states (based on geographic diversity, with a preference to states with a prevalence of opioid use disorders comparable to or higher than the national average). Planning grant activities include assessing the behavioral health treatment needs of the state and supporting the development of state infrastructure to recruit prospective providers to treat substance use disorders and training for those providers. The maximum time period for funding for planning grants is 18 months.
General information about this opportunity
Last Known Status
Centers For Medicare and Medicaid Services, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, or the SUPPORT for Patients and Communities Act, Section Section 1003, Public Law 115-271
Who is eligible to apply/benefit from this assistance?
The statutory authority limits eligibility to states including the District of Columbia. Eligible applicants are State Medicaid Agencies (SMAs).
Planning grants are aimed to increase the capacity of Medicaid providers to provide SUD treatment or recovery services to: Medicaid eligible individuals; low income individuals/families; individuals with disabilities; consumers; individuals with behavioral health disorders including mental health and substance use disorders.
What is the process for applying and being award this assistance?
Preapplication coordination is required. Applicants are encouraged to submit a non-binding Notice of Intent to Apply. Notices of Intent to Apply are not required and their submission or failure to submit a notice has no bearing on the scoring of proposals received. Receipt of such notices enables CMS to better plan for the application review process.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must submit their applications electronically through http://www.grants.gov. Applicants are encouraged to submit a non-binding Letter of Intent to Apply. Letters of Intent to Apply are not required and a state's submission or failure to submit a letter has no bearing on the scoring of proposals received. Applicants should review the application and submission information in the funding opportunity announcement for specific instructions on applying for this grant program.
Applications are awarded based on the outcomes of the Federal review panel. An independent review of all applications will be conducted by a panel of experts. The review panel will assess each application to determine the merits of the proposal. CMS reserves the right to request that states revise or otherwise modify certain sections of their proposals based on the recommendations of the panel and the budget. Final approval of the SUPPORT ACT planning grant awards will be made by CMS after consideration of the comments and recommendations of the review panelists, program office recommendations, and the availability of funds. CMS reserves the right to approve or deny any or all proposals for funding.
Letter of Intent to Apply Due Date: July 18, 2019 Electronic Application Due Date: August 9, 2019
Approval/Disapproval Decision Time
Contact the regional office for application deadlines. Successful applicants will receive a Notice of Award (NoA) on or before September 30, 2019. Any communication between CMS and applicants prior to issuance of the NoA is not an authorization to begin performance of a project. Unsuccessful applicants will be notified by letter, sent through the U.S. Postal Service to the applicant organization as listed on its SF- 424, after September 30, 2019.
Appeals are governed by Title 45--Public Welfare SUBTITLE A--DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 16--PROCEDURES OF THE DEPARTMENTAL GRANT APPEALS BOARD.
Planning grants agreements are funded on an 18-month basis, with support subsequent years contingent upon acceptable evidence of satisfactory progress, continuing program relevance, and availability of funds. For purposes of the Planning Grants, there is appropriated, out of any funds in the Treasury not otherwise appropriated, $50,000,000, to remain available until expended.
How are proposals selected?
Applications will be screened by Federal staff to determine eligibility for further review using the criteria detailed in the "Eligibility Information" section of this solicitation. Applications that are received late or fail to meet the eligibility requirements as detailed in the "Applicant Eligibility" section of this solicitation will not be reviewed. Applications will be objectively reviewed by a panel of CMS and SAMHSA experts, the exact number and composition of which will be determined by CMS at its discretion, but may include subject matter experts and Federal policy staff. Subject matter experts from other Federal agencies may be included at CMS discretion. The review panel will utilize the objective criteria described in the "Application Review Criteria Information" section of this solicitation to establish an overall numeric score for each application. The results of the objective review of applications will be used to advise the approving CMS official. Additionally, CMS staff will make final recommendations to the approving official after ranking applications using the scores and comments from the review panel and weighing other factors based on geographic diversity, with a preference to states with a prevalence of opioid use disorders comparable to or higher than the national average.
How may assistance be used?
Section 1003 (aa)(3) (B)(i-iii) requires CMS to select states for planning grants using the following criteria:
-Select States with an approved Medicaid State plan (or waiver of the State plan)
-Select States in a manner that ensures geographic diversity
-Give preference to States with a prevalence of substance use disorders (in particular opioid use disorders) that is comparable to or higher than the national average prevalence, as measured by aggregate per capita drug overdoses, or any other measure that CMS deems appropriate.
What are the requirements after being awarded this opportunity?
Performance monitoring is not required.
Recipients are required to maintain grant accounting records 3 years after the date the grant is officially closed. If any litigation, claim, negotiation, audit or other action involving the award has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Planning grants are awarded for an 18 month period; funds must be expended within 18 months of award. Method of awarding/releasing assistance: Lump.
Who do I contact about this opportunity?
Regional or Local Office
Melanie M. Brown PhD, MPH Centers for Medicare & Medicaid Services 7500 Security Boulevard Mail Stop: S2-13-20 Baltimore, MD 21244-1850 email@example.com Melanie M. Brown PhD, MPH Centers for Medicare & Medicaid Services 7500 Security Boulevard Mail Stop: S2-13-20 Baltimore, MD 21244-1850 firstname.lastname@example.org
Melanie M. Brown Ph.D., MPH
7500 Security Boulevard
Baltiimore, MD 21244 USA
Melanie M. Brown Ph.D., MPH
7500 Security Boulevard
Baltimore, MD 21244 USA
(Project Grants) FY 18$0.00; FY 19 est $50,000,000.00; FY 20 est $0.00; - N/A
Range and Average of Financial Assistance
Regulations, Guidelines and Literature
Examples of Funded Projects